Alembic Pharma Q2 Results: Firm posts Rs 133 crore-profit
The company reported Rs 164 crore in net profit in Q2FY22. Revenues dropped 12% YoY to Rs 1475 crore in Q2FY23 compared to Rs 1313 crore last year.The earnings before interest, tax, depreciation and amortization (EBITA) declined 13% YoY to Rs 231 crore. The EBITDA margins stood at 16% in Q2FY23